Matthias Löhr ʚїɞ
@maloehr.bsky.social
📤 472
📥 143
📝 164
Professor of Gastroenterology at
#Karolinska
Institutet.
#Pancreas
lover.
reposted by
Matthias Löhr ʚїɞ
United European Gastroenterology
4 days ago
Applications for UEG Summer School 2026 are opening in one week, on January 15 – mark your calendar and get ready! 🆕 New for 2026: Extended to three full days for even more practical training and collaboration 📍 11 – 14 June, Prague, Czech Republic 🔗 Learn more:
https://bit.ly/3qTAD6C
0
0
1
Today, I leave as the president of
@myueg.bsky.social
It was a pleasure to serve our federation "onwards & upwards"! Handover of office was during
#UEGWeek
;
@joostphdrenth.bsky.social
was a phantastic vice president and will serve as an excellent president! This is the last
#selfiewiththepresident
11 days ago
0
1
1
We are proud that our comment on the future of
#treating
#pancreaticexocrineinsufficiency
with
#pancreatin
will be the opening article for
@natrevgastrohep.nature.com
in 2026!
doi.org/10.1038/s415...
loading . . .
The future of treating pancreatic exocrine insufficiency - Nature Reviews Gastroenterology & Hepatology
Patients with pancreatic exocrine insufficiency are treated with pancreatic enzyme replacement therapy. However, there are several challenges facing the future of this treatment, including infectious ...
https://doi.org/10.1038/s41575-025-01150-z
12 days ago
0
1
0
This
#grandchallege
#PANORAMA
study was part of our
#PANCAIM
🇪🇺 project led by
@radboudumc.bsky.social
add a skeleton here at some point
about 1 month ago
0
2
1
reposted by
Matthias Löhr ʚїɞ
United European Gastroenterology
about 1 month ago
Today is International Volunteer Day – and the perfect moment to say a big THANK YOU to our wonderful volunteers. Your dedication, passion, and support make everything we do possible. We couldn’t do it without you!
@maloehr.bsky.social
0
2
1
Today is the day!
add a skeleton here at some point
about 1 month ago
0
3
0
reposted by
Matthias Löhr ʚїɞ
PANCAID
about 1 month ago
📺 Happening now!
@scienceinnovation.ec.europa.eu
is hosting "Advancing cancer care: personalised treatment and innovation" Prof. Klaus Pantel is panelist in the session "From Detection to Decision: Cutting-Edge Diagnostics in Precision Cancer Care." 👉 Watch here:
www.youtube.com/live/z3qA1nQ...
loading . . .
Advancing cancer care: personalised treatment and innovation (part I)
YouTube video by EU Science & Innovation
https://www.youtube.com/live/z3qA1nQwDCk?si=l5_akw3J-lyArE7U&t=3510
0
2
1
Today on
#givingtuesday
make gift 🎁 for
#pancreaticcancer
research to
@ki.se
we need all the support, not only but also finacially 💰 that we can get. Donators will be named, as documented in our publications 📄!
about 1 month ago
0
0
0
reposted by
Matthias Löhr ʚїɞ
Nature
about 1 month ago
Obituary: David Baltimore (1938-2025) virologist whose enzyme discovery transformed understanding of cancer and HIV/AIDS
go.nature.com/443Vojo
loading . . .
David Baltimore obituary: virologist whose enzyme discovery transformed understanding of cancer and HIV/AIDS
The protein, reverse transcriptase, has become an essential tool for making DNA copies of RNA.
https://go.nature.com/443Vojo
0
65
20
reposted by
Matthias Löhr ʚїɞ
NEJM AI
about 1 month ago
Perspective by Richard K. Leuchter, MD, William B. Turner, BA, and David Ouyang, MD: Evaluating Translational AI: A Two-Way Moving Target Problem
nejm.ai/3LFovDj
#AI
#MedSky
#MLSky
0
3
1
reposted by
Matthias Löhr ʚїɞ
Nature Reviews Gastroenterology & Hepatology
about 1 month ago
New online! The 3 Ps of IBD today — prevention, pre-diagnosis and participation
loading . . .
The 3 Ps of IBD today — prevention, pre-diagnosis and participation
Nature Reviews Gastroenterology & Hepatology, Published online: 28 November 2025; doi:10.1038/s41575-025-01157-6In summary, 2025 has seen a shift in focus from pure therapeutic management to active disease prevention. The message is unambiguous. The next breakthrough in IBD will not emerge solely from new drugs or biologics, but from reimagining how we live, eat and engage with the microbial ecosystems that define our health.
https://www.nature.com/articles/s41575-025-01157-6?utm_source=bluesky&utm_medium=social&utm_campaign=nrgastro
0
5
1
Another
#selfiewiththepresident
with the president of the Turkish Gastroenterology Society
#TSG
#mehmetcindoruk
in Antalya 🇹🇷 Excellent science!
about 2 months ago
0
1
0
Thanks for pointing out our
#PANORAMA
study from
#PANCAIM
@euprojectpulse.bsky.social
This is the future of
#pancreaticcancer
#earlydetection
! Published in
@thelancet.com
oncology
add a skeleton here at some point
about 2 months ago
1
3
1
One of the most pressning issues the
@myueg.bsky.social
is prominently and continuously addressing!
add a skeleton here at some point
about 2 months ago
0
2
1
reposted by
Matthias Löhr ʚїɞ
Nature
about 2 months ago
Engineered T cells that have been used to treat ulcerative colitis, rheumatoid arthritis and lupus show promising results
go.nature.com/3MaSKC9
loading . . .
‘They don’t have symptoms’: CAR-T therapies send autoimmune diseases into remission
Engineered T cells that have been used to treat ulcerative colitis, rheumatoid arthritis and lupus show promising results.
https://go.nature.com/3MaSKC9
0
100
21
reposted by
Matthias Löhr ʚїɞ
Lesley Goodburn
about 2 months ago
www.clinicaltrialsarena.com/news/amorphi...
loading . . .
Amorphical enrols first subject in Phase II trial of pancreatic cancer therapy
Amorphical has enrolled the first participant in a Phase II clinical trial assessing its nano-amorphous mineral-based therapy for stage IV pancreatic cancer.
https://www.clinicaltrialsarena.com/news/amorphical-first-subject-trial/
0
1
1
reposted by
Matthias Löhr ʚїɞ
Deutsches Krebsforschungszentrum (DKFZ)
about 2 months ago
Dreaming of a career in cancer research? Join the International PhD Program at DKFZ - Germany’s largest biomedical research center. Explore
#cancerresearch
including
#cancerbiology
,
#bioinformatics
,
#epidemiology
&
#medicalphysics
. The Winter Selection is open now 👉 apply
t1p.de/hl56b
0
3
2
reposted by
Matthias Löhr ʚїɞ
United European Gastroenterology
about 2 months ago
The EU agrees on the 2026 budget with €13bn for Horizon Europe 💶 Explore digestive health calls and funding opportunities from the Horizon Europe Work Programme 2026–2027 here: 🔗
https://bit.ly/4odr6Sz
The UEG Start-up Grant can support you every step of the way: 🔗
https://bit.ly/3ASF4Gq
0
3
1
reposted by
Matthias Löhr ʚїɞ
Nature Reviews Gastroenterology & Hepatology
about 2 months ago
Our DECEMBER ISSUE is live! Hepatic T cells, microbiome and pancreatic cancer, portal hypertension and cirrhosis, metabolic and alcohol-related liver disease and much more!
www.nature.com/nrgastro/vol...
2
11
7
Writing from
#Brussels
@ec.europa.eu
where we are meeting for our 🇪🇺 project
@pancaid.bsky.social
#pancreaticcancer
is still a medical emergency!
add a skeleton here at some point
about 2 months ago
0
6
2
Such a pleasure to lead this consortium together with
#klauspantel
from
#UKE
!
@ki.se
is participating with several departments including
#CLINTEC
,
#LIME
,
#NVS
#yvonnewengström
#niklaszethraeus
add a skeleton here at some point
about 2 months ago
0
1
1
reposted by
Matthias Löhr ʚїɞ
Nature Reviews Gastroenterology & Hepatology
about 2 months ago
ICYMI: New online! Improving surgical treatments for hepatocellular carcinoma
loading . . .
Improving surgical treatments for hepatocellular carcinoma
Nature Reviews Gastroenterology & Hepatology, Published online: 17 November 2025; doi:10.1038/s41575-025-01143-yThis Review examines how advances in tumour biology, immunogenomics and graft preservation are redefining surgical management of hepatocellular carcinoma. Malik et al. describe the shift from anatomical to biology-informed paradigms to individualize surgical decision-making.
https://www.nature.com/articles/s41575-025-01143-y?utm_source=bluesky&utm_medium=social&utm_campaign=nrgastro
0
3
2
And still continuing! In the series
#selfiewiththepresident
here with
#melindabellin
, President of the
#americanpancreaticassociation
#APA
during their annual meeting in
#sandiego
🇺🇸. Excellent, meeting with old friends and making new friends
about 2 months ago
0
0
0
Please read "The future of treating pancreatic exocrine insufficiency" in
@natrevgastrohep.nature.com
following the
@myueg.bsky.social
- guidelines on
#pancreaticexocrineinsufficiency
, published in
#UEGJournal
. In short, we should search for non-porcine alternatives for
#PERT
.
rdcu.be/ePxW0
loading . . .
The future of treating pancreatic exocrine insufficiency
Nature Reviews Gastroenterology & Hepatology - Patients with pancreatic exocrine insufficiency are treated with pancreatic enzyme replacement therapy. However, there are several challenges...
https://rdcu.be/ePxW0
about 2 months ago
0
3
2
Join the best team in association management in Europe!
add a skeleton here at some point
2 months ago
0
3
0
reposted by
Matthias Löhr ʚїɞ
Marc Besselink
2 months ago
Wonderful 2nd BCIPCC meeting
#Lisbon
🇵🇹 ⏩️
bcipcc.org
Today included
#ISGPS
and
#Robot
#Pancreatic
#Surgery
sessions: ✅
#ISGPS
is working on improved and simplified definitions for DGE and PPH ✅
#DIPLOMA3
trial Robot vs Lap Pancreatectomy is ongoing!
0
4
2
More important than ever!
add a skeleton here at some point
2 months ago
0
2
0
reposted by
Matthias Löhr ʚїɞ
United European Gastroenterology
2 months ago
Together, we’re advancing pancreatic cancer care across Europe. 🌍 Since the #PancreaticCancer Position Paper was published in May 2024, we’ve been turning its recommendations into action – improving prevention, early detection & care. 👉 Learn more:
https://bit.ly/3JzYNiC
#PancreaticCancer
#EUNewsline
1
4
5
reposted by
Matthias Löhr ʚїɞ
EssJay PURPLE PURPOSE
2 months ago
Via
Lustgarten.org
Pancreatic cancer is often diagnosed late — but what if we could catch it earlier, when it’s still curable? A Live-streamed symposium Nov 19 “Unlocking Early Detection.” Register here! ⬇️
events.zoom.us/ev/Aok47nnHF...
loading . . .
Unlocking Early Detection: From Precancerous Clues to AI-Driven Discovery
https://events.zoom.us/ev/Aok47nnHFlU8wqzwUTBwi_Z2TWh-jv8JqZ3pFskv125TEGalI5zZ~AnjMF6s81fjlA8GZCDPI69XTGgGBwMaKcejOiiUE9re3dAVInFnYrb2paW-C5HY8LN2TI9k31YF9wiCUTSTcFIpIGQ?utm_source=Lustgarten+Foundation+General&utm_campaign=a1e20b1711-ll-nov2025-ued-msg1&utm_medium=email&utm_term=0_a3c8ec0718-a1e20b1711-222232985
2
1
1
reposted by
Matthias Löhr ʚїɞ
Nature Reviews Drug Discovery
2 months ago
Our November issue is live! Read more about drugs for cancer cachexia, RNA chemistry and therapeutics, targeting the Hippo pathway in cancer, the changing landscape of medicinal chemistry optimization and more here
www.nature.com/nrd/volumes/...
0
5
2
Both
@nuriamalats.bsky.social
& me at
@champalimaudf.bsky.social
2nd International meeting on
#pancreaticcancer
@peterbaileychamp.bsky.social
from the
#PANCAIM
/
#PANORAMA
@radboudumc.bsky.social
and
@pancaid.bsky.social
@euprojectpulse.bsky.social
EU projects! Great discussions w/ our US friends!
2 months ago
0
4
2
Opening the 2nd
#Botton-Champalimaud
international conference on
#pancreaticcancer
by
#MarkusBüchler
&
@peterbaileychamp.bsky.social
w/ the 1st speaker
#marianobarbacid
@cniostopcancer.bsky.social
on
#KRAS
from his discovery to
#krasinhibitors
. What a journey! Short of a breakthrough in
#PDAC
!
2 months ago
0
1
1
Today
#PhD
by
#LinneaMalgerud
@ki.se
on
#pancreaticcancer
diagnostics and therapy with
#lenaconradi
as the opponent! Excellent presentation and defense!
2 months ago
0
0
0
Please apply
@myueg.bsky.social
to boost your career!
3 months ago
0
1
0
The interactive graphics online is just great for learning! Very well done!
add a skeleton here at some point
3 months ago
0
0
0
This
#UKBiobank
🩸 is a unique resource, not only for 🧬 but also for protein
#biomarkers
add a skeleton here at some point
3 months ago
0
0
0
KRAS inhibition (together with other substances) will be a breakthrough in the treatment of
#pancreaticancer
add a skeleton here at some point
3 months ago
1
1
1
Whatever it takes to conquer
#pancreaticcancer
add a skeleton here at some point
3 months ago
0
0
0
reposted by
Matthias Löhr ʚїɞ
United European Gastroenterology
3 months ago
Congratulations to our Rising Stars 2025! 🌟 Selected for their outstanding early career achievements & scientific excellence, they represent the future of digestive health. Watch their presentations now on the congress platform (available to all UEG Week delegates): 🔗
https://bit.ly/4ooqDxb.
1
1
1
reposted by
Matthias Löhr ʚїɞ
Karolinska Institutet
3 months ago
The specific weight loss properties of GLP-1R agonists are key to improving neurological recovery after
#stroke
in diabetic mice, according to a new study from Karolinska Institutet and Södersjukhuset published in
@diabetologiajnl.bsky.social
🧪
#diabetes
doi.org/10.1007/s001...
loading . . .
Pre-stroke weight loss by glucagon-like peptide 1 receptor and neuropeptide Y receptor Y2 activation improves post-stroke functional recovery in male diabetic mouse models - Diabetologia
Aims/hypothesis Type 2 diabetes is associated with worsened stroke outcome and lasting disability. The underlying mechanisms are undetermined, and no therapy is available. We experimentally investigat...
https://doi.org/10.1007/s00125-025-06567-4
1
4
2
reposted by
Matthias Löhr ʚїɞ
Pancreatic Cancer Europe
3 months ago
A pancreatic cancer diagnosis affects not only the body but also the mind. 🧠 Through our Emotional Support and Pancreatic Cancer Project, we aim to make mental health a core part of cancer care. 👉 Find useful resources here:
pancreaticcancereurope.eu/project/emot...
0
1
1
reposted by
Matthias Löhr ʚїɞ
United European Gastroenterology
3 months ago
Scientists and clinicians can play a key role in transforming social media from a threat into a powerful tool for truth💡 Check out highlights from Wendi LeBrett's talk at the Opening Plenary of
#UEGWeek
, where she shares her perspective on how to fight fake news in medicine.
0
2
2
reposted by
Matthias Löhr ʚїɞ
Karolinska Institutet
3 months ago
Eating a healthy plant-based diet may lower the risk of
#dementia
in older people with cardiovascular diseases, type 2 diabetes, or stroke, and the quality of the plant-based diet could be crucial. This is according to a new KI study published in JACC: Advances 🧪
news.ki.se/plant-based-...
1
7
5
#UEGWeek
2025 is over&done. A truly global event with 12k participants from 115 countries - mostly from 🇪🇺 but all around the 🌎 with large fraction from 🇺🇸 and 🇯🇵 We are looking forward to another edition next year in Barcelona! Stay tuned
@myueg.bsky.social
3 months ago
0
2
2
Well, the latest and presumably last in the famous series
#selfiewiththepresident
with incoming
@myueg.bsky.social
president
@joostphdrenth.bsky.social
on the opportunity of
#UEGWeek
. He promised to continue the series! Stay tuned!
3 months ago
0
4
1
reposted by
Matthias Löhr ʚїɞ
United European Gastroenterology
3 months ago
ESD vs. TAMIS for large rectal lesions.
#UEGWeek
top abstract awardee Nik Dekkers shares results from a landmark multicentre trial, revealing that ESD could be a safe, effective and potentially superior alternative to local surgery for large rectal lesions 🔍
loading . . .
0
1
1
reposted by
Matthias Löhr ʚїɞ
United European Gastroenterology
3 months ago
💡 Stay at the forefront of science! Today’s 'Late Breakers' session brings you cutting-edge updates in: Digestive Oncology • Endoscopy • Neurogastroenterology & Motility • Oesophagus • Stomach & H.Pylori 📍 Room A1 | 🕝 14:30 – 15:30 CEST 🔗
https://bit.ly/47OEoAi
#UEGWeek
0
1
1
It is utterly important to screen - the right people but not everybody.
add a skeleton here at some point
3 months ago
0
2
2
reposted by
Matthias Löhr ʚїɞ
United European Gastroenterology
3 months ago
Watch as
#UEGWeek
presenter Andreas E. Kremer walks us through the efficacy of linerixibat, providing sustained relief of pruritus in patients with primary biliary cholangitis (PBC) – a promising, targeted therapy addressing a major unmet need in this population.
loading . . .
0
2
1
Was a top abstract 🏆 winner, too!
add a skeleton here at some point
3 months ago
0
2
0
Load more
feeds!
log in